A detailed history of Journey Advisory Group, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Journey Advisory Group, LLC holds 1,716 shares of ZTS stock, worth $303,234. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,716
Previous 1,716 -0.0%
Holding current value
$303,234
Previous $297,000 12.79%
% of portfolio
0.04%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$165.67 - $199.94 $14,081 - $16,994
85 Added 5.21%
1,716 $290,000
Q4 2023

Feb 12, 2024

BUY
$151.44 - $200.09 $246,998 - $326,346
1,631 New
1,631 $321,000
Q2 2023

Aug 09, 2023

BUY
$160.94 - $186.23 $23,014 - $26,630
143 Added 9.45%
1,656 $285,000
Q1 2023

May 04, 2023

BUY
$145.48 - $175.02 $220,111 - $264,805
1,513 New
1,513 $251,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Journey Advisory Group, LLC Portfolio

Follow Journey Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Journey Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Journey Advisory Group, LLC with notifications on news.